Feng Liu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Feng Liu has a total of 73 co-authors. Here are the top co-authors by number of shared publications:
- Yonggang Wu
Institute of Life Science and Green Development & College of Chemistry and Materials Science Hebei University 180 Wusi Road Baoding 071002 China
7 shared publications - Xinwu Ba
College of Chemistry and Materials Science, Hebei University, Baoding 071002, China
4 shared publications Yuangong Zhang
4 shared publicationsChenhao Wang
BSchool of Basic Medical Sciences, Hebei University, Baoding, 071002, PR China
3 shared publicationsJie Zhang
Key Laboratory of Pathogenesis Mechanism and Control of Inflammatory Autoimmune Disease of Hebei Province, School of Basic Medicine Science, Hebei University
3 shared publicationsLibin Bai
3 shared publications
Latest Publications
- 7 July 2026
- Published by Springer Nature in Polymer Bulletin
- Vol. 83 (10)
Engineering low-PDI hyperbranched polymannose via one-pot RAFT/tandem strategy for biomimetic lectin separation
- 7 July 2026
- Published by Springer Nature in Polymer Bulletin
- Vol. 83 (10)
Engineering low-PDI hyperbranched polymannose via one-pot RAFT/tandem strategy for biomimetic lectin separation
- Open Access
- 7 April 2026
- Published by American Society for Microbiology in Microbiology Spectrum
- Vol. 14 (4) , e0258825
Targeting MCR-3 and membrane biosynthesis: mechanistic insights into pterostilbene-colistin synergy
Colistin is a crucial antibiotic for treating infections caused by multidrug-resistant Enterobacterales. However, the emergence of plasmid-mediated mcr genes has significantly compromised their clinical efficacy. Natural adjuvants, such as pterostilbene, offer a promising strategy to restore antibiotic efficacy against resistant bacteria. This study aims to elucidate the molecular mechanisms underlying the synergistic action between pterostilbene and colistin (polymyxin E) against mcr-3 -positive Escherichia coli . The in vitro synergistic activity between pterostilbene and colistin was confirmed by checkerboard assays. This effect was further supported by bacterial viability and membrane potential analysis. In the Galleria mellonella infection model, combination therapy also demonstrated therapeutic efficacy. Molecular docking revealed that pterostilbene directly targets key catalytic residues (H380 and E111) of the MCR-3 enzyme, inhibiting its phosphoethanolamine transferase activity, a finding validated by site-directed mutagenesis. Transcriptomic analysis further revealed that pterostilbene downregulated genes involved in fatty acid biosynthesis and central carbon metabolism while upregulating fatty acid degradation pathways. These metabolic disruptions were associated with compromised membrane integrity, as confirmed by electron microscopy and membrane permeability assays. Supplementation with exogenous phospholipids attenuated the synergistic effect, supporting a lipid-mediated mechanism. This study demonstrates that pterostilbene enhances colistin efficacy through dual mechanisms: direct inhibition of MCR-3 enzymatic function and disruption of bacterial membrane stability. These findings provide a strong theoretical foundation for developing pterostilbene-based adjuvants to combat mcr -mediated colistin resistance. IMPORTANCE: Colistin remains one of the last therapeutic options for infections caused by multidrug-resistant Enterobacteriaceae, but plasmid-borne mcr genes threaten their utility. We identified that the natural compound pterostilbene restores polymyxin activity against mcr-3 -positive Escherichia coli through dual mechanisms: direct inhibition of MCR-3 catalytic residues and disruption of membrane stability via metabolic reprogramming. These dual actions compromise resistance and enhance bacterial killing both in vitro and in vivo . Our findings provide mechanistic insight into a plant-derived molecule that could be developed to counteract colistin resistance, highlighting a promising approach for extending the lifespan of critical last-line antibiotics.
- 7 April 2026
- Published by American Society for Microbiology in Microbiology Spectrum
- Vol. 14 (4) , e0258825
Open AccessTargeting MCR-3 and membrane biosynthesis: mechanistic insights into pterostilbene-colistin synergy
Colistin is a crucial antibiotic for treating infections caused by multidrug-resistant Enterobacterales. However, the emergence of plasmid-mediated mcr genes has significantly compromised their clinical efficacy. Natural adjuvants, such as pterostilbene, offer a promising strategy to restore antibiotic efficacy against resistant bacteria. This study aims to elucidate the molecular mechanisms underlying the synergistic action between pterostilbene and colistin (polymyxin E) against mcr-3 -positive Escherichia coli . The in vitro synergistic activity between pterostilbene and colistin was confirmed by checkerboard assays. This effect was further supported by bacterial viability and membrane potential analysis. In the Galleria mellonella infection model, combination therapy also demonstrated therapeutic efficacy. Molecular docking revealed that pterostilbene directly targets key catalytic residues (H380 and E111) of the MCR-3 enzyme, inhibiting its phosphoethanolamine transferase activity, a finding validated by site-directed mutagenesis. Transcriptomic analysis further revealed that pterostilbene downregulated genes involved in fatty acid biosynthesis and central carbon metabolism while upregulating fatty acid degradation pathways. These metabolic disruptions were associated with compromised membrane integrity, as confirmed by electron microscopy and membrane permeability assays. Supplementation with exogenous phospholipids attenuated the synergistic effect, supporting a lipid-mediated mechanism. This study demonstrates that pterostilbene enhances colistin efficacy through dual mechanisms: direct inhibition of MCR-3 enzymatic function and disruption of bacterial membrane stability. These findings provide a strong theoretical foundation for developing pterostilbene-based adjuvants to combat mcr -mediated colistin resistance. IMPORTANCE: Colistin remains one of the last therapeutic options for infections caused by multidrug-resistant Enterobacteriaceae, but plasmid-borne mcr genes threaten their utility. We identified that the natural compound pterostilbene restores polymyxin activity against mcr-3 -positive Escherichia coli through dual mechanisms: direct inhibition of MCR-3 catalytic residues and disruption of membrane stability via metabolic reprogramming. These dual actions compromise resistance and enhance bacterial killing both in vitro and in vivo . Our findings provide mechanistic insight into a plant-derived molecule that could be developed to counteract colistin resistance, highlighting a promising approach for extending the lifespan of critical last-line antibiotics.
- 13 June 2025
- Published by Elsevier in European Polymer Journal
- Vol. 235
Dual-Responsive fluorinated glycopolymers Targeting GLUT1 for enhanced BBB penetration and Activatable 19F MRI imaging
- 13 June 2025
- Published by Elsevier in European Polymer Journal
- Vol. 235
Dual-Responsive fluorinated glycopolymers Targeting GLUT1 for enhanced BBB penetration and Activatable 19F MRI imaging
- 14 March 2025
- Published by CSIRO Publishing in Australian Journal of Chemistry
- Vol. 78 (3)
Synthesis of novel mono BN substituted symmetrical and asymmetrical perylene diimides for fluoride anion detection
Three novel mono BN substituted perylene diimide (PDI) derivatives, namely PDI-BN1, PDI-BN2 and PDI-BN3, were designed and efficiently synthesised using a concise synthetic strategy. Their molecular structures were confirmed by NMR, high-resolution mass spectrometry and FTIR. The electronic and optical characteristics were also comparatively studied. These BN substituted PDI derivatives exhibited orange fluorescence, with their properties finely adjustable by integrating various fused aryl rings. Except for F− ions, all the BN substituted PDI derivatives have shown no affinity for other anions, such as Cl−, Br−, I−, NO3−, AcO−, BF4−, PF6−, ClO4−, H2PO4− and SO42−. Cytotoxic evaluation on HeLa cells revealed that PDI-BN1 was found to be non-toxic, and cellular imaging studies were carried out to authenticate the real applicability of PDI-BN1 in F− ion detection.
- 14 March 2025
- Published by CSIRO Publishing in Australian Journal of Chemistry
- Vol. 78 (3)
Synthesis of novel mono BN substituted symmetrical and asymmetrical perylene diimides for fluoride anion detection
Three novel mono BN substituted perylene diimide (PDI) derivatives, namely PDI-BN1, PDI-BN2 and PDI-BN3, were designed and efficiently synthesised using a concise synthetic strategy. Their molecular structures were confirmed by NMR, high-resolution mass spectrometry and FTIR. The electronic and optical characteristics were also comparatively studied. These BN substituted PDI derivatives exhibited orange fluorescence, with their properties finely adjustable by integrating various fused aryl rings. Except for F− ions, all the BN substituted PDI derivatives have shown no affinity for other anions, such as Cl−, Br−, I−, NO3−, AcO−, BF4−, PF6−, ClO4−, H2PO4− and SO42−. Cytotoxic evaluation on HeLa cells revealed that PDI-BN1 was found to be non-toxic, and cellular imaging studies were carried out to authenticate the real applicability of PDI-BN1 in F− ion detection.
- Open Access
- 15 February 2025
- Published by Royal Society of Chemistry (RSC) in Materials Advances
- Vol. 6 (6) , 1959-1964
Novel polydopamine/halloysite nanotube-reinforced brushite calcium phosphate cement for bone regeneration with synergistic regulation of mechanical/osteogenic capacity
Bone regeneration remains a clinical challenge with limited bone substitutes. Brushite calcium phosphate cements (Bru-CPCs), possessing good bioactivity and biocompatibility, are one of the widely studied bone graft materials. However, their further application in the long-term remodeling of bone is limited by the low compressive strength. Adding additives has been a promising strategy to solve the above problem. Herein, halloysite nanotubes (HNTs) with a unique rod-like structure and excellent biocompatibility were chosen as reinforced materials to fabricate bone repair materials. Inspired by the adhesive proteins in mussels, we modified the HNTs’ surface with polydopamine (PDA) to improve the inorganic–inorganic phase interfacial interactions between the HNTs and Bru-CPCs. Bru-CPCs, Bru-CPCs/1.5%HNTs and Bru-CPCs/1.5%HNTs@PDA were fabricated and the mechanical properties and biological activity of the bone repair materials were evaluated in detail. All the results indicated that Bru-CPCs incorporated with 1.5 wt% HNTs@PDA have good compressive strength and osteo-differentiation properties, making them a prospective biomaterial for bone-tissue repair.
- 15 February 2025
- Published by Royal Society of Chemistry (RSC) in Materials Advances
- Vol. 6 (6) , 1959-1964
Open AccessNovel polydopamine/halloysite nanotube-reinforced brushite calcium phosphate cement for bone regeneration with synergistic regulation of mechanical/osteogenic capacity
Bone regeneration remains a clinical challenge with limited bone substitutes. Brushite calcium phosphate cements (Bru-CPCs), possessing good bioactivity and biocompatibility, are one of the widely studied bone graft materials. However, their further application in the long-term remodeling of bone is limited by the low compressive strength. Adding additives has been a promising strategy to solve the above problem. Herein, halloysite nanotubes (HNTs) with a unique rod-like structure and excellent biocompatibility were chosen as reinforced materials to fabricate bone repair materials. Inspired by the adhesive proteins in mussels, we modified the HNTs’ surface with polydopamine (PDA) to improve the inorganic–inorganic phase interfacial interactions between the HNTs and Bru-CPCs. Bru-CPCs, Bru-CPCs/1.5%HNTs and Bru-CPCs/1.5%HNTs@PDA were fabricated and the mechanical properties and biological activity of the bone repair materials were evaluated in detail. All the results indicated that Bru-CPCs incorporated with 1.5 wt% HNTs@PDA have good compressive strength and osteo-differentiation properties, making them a prospective biomaterial for bone-tissue repair.
- Open Access
- 1 January 2025
- Published by American Association for the Advancement of Science (AAAS) in Biomaterials Research
- Vol. 29, 0213
Polydopamine/Montmorillonite-Based Brushite Calcium Phosphate Cements: Synergize Mechanical and Osteogenic Capacity for Bone Regeneration
Although brushite calcium phosphate cements (Bru-CPCs) possess good bioactivity and biocompatibility, their low compressive strength hinders their effective application in osteoporotic bone defect treatment. Therefore, the aim of this study was to improve the compressive strength without sacrificing the osteogenesis properties of Bru-CPCs. Montmorillonite (MMT) was added into Bru-CPCs to get Bru-CPCs/1.5% MMT. The compressive strength of Bru-CPCs/1.5% MMT increased to 13.31 MPa, but the interfacial interactions between MMT and Bru-CPCs (inorganic–inorganic phase) limited further improvement in compressive strength. Inspired by the adhesive proteins in mussels, MMT was coated with a polydopamine (PDA) layer to get MMT@PDA. The compressive strength of Bru-CPCs/1.5% MMT@PDA further increased to 16.58 MPa. Then, the surface morphology, adhesiveness, biocompatibility, and bioactivity of CPCs/1.5% MMT@PDA were evaluated. All data indicated that by adding MMT@PDA, the compressive strength was improved without sacrificing the osteogenesis properties of Bru-CPCs.
- 1 January 2025
- Published by American Association for the Advancement of Science (AAAS) in Biomaterials Research
- Vol. 29, 0213
Open AccessPolydopamine/Montmorillonite-Based Brushite Calcium Phosphate Cements: Synergize Mechanical and Osteogenic Capacity for Bone Regeneration
Although brushite calcium phosphate cements (Bru-CPCs) possess good bioactivity and biocompatibility, their low compressive strength hinders their effective application in osteoporotic bone defect treatment. Therefore, the aim of this study was to improve the compressive strength without sacrificing the osteogenesis properties of Bru-CPCs. Montmorillonite (MMT) was added into Bru-CPCs to get Bru-CPCs/1.5% MMT. The compressive strength of Bru-CPCs/1.5% MMT increased to 13.31 MPa, but the interfacial interactions between MMT and Bru-CPCs (inorganic–inorganic phase) limited further improvement in compressive strength. Inspired by the adhesive proteins in mussels, MMT was coated with a polydopamine (PDA) layer to get MMT@PDA. The compressive strength of Bru-CPCs/1.5% MMT@PDA further increased to 16.58 MPa. Then, the surface morphology, adhesiveness, biocompatibility, and bioactivity of CPCs/1.5% MMT@PDA were evaluated. All data indicated that by adding MMT@PDA, the compressive strength was improved without sacrificing the osteogenesis properties of Bru-CPCs.
- 31 October 2024
- Published by American Chemical Society (ACS) in ACS Applied Polymer Materials
- Vol. 6 (21) , 13182-13192
Simple Route to Functional Cyclized/Knotted PManEMA-co-IMs: One-Pot RAFT/Hydroxyl–Isocyanate Reaction
- 31 October 2024
- Published by American Chemical Society (ACS) in ACS Applied Polymer Materials
- Vol. 6 (21) , 13182-13192
Simple Route to Functional Cyclized/Knotted PManEMA-co-IMs: One-Pot RAFT/Hydroxyl–Isocyanate Reaction
- 11 March 2024
- Published by American Chemical Society (ACS) in ACS Biomaterials Science & Engineering
- Vol. 10 (4) , 2062-2067
Simultaneous Regulation of the Mechanical/Osteogenic Capacity of Brushite Calcium Phosphate Cement by Incorporating with Poly(ethylene glycol) Dicarboxylic Acid
Brushite calcium phosphate cement (brushite CPC) is a prospective bone repair material due to its ideal resorption rates in vivo. However, the undesirable mechanical property and bioactivity limited its availability in clinic application. To address this issue, incorporating polymeric additives has emerged as a viable solution. In this study, poly(ethylene glycol) dicarboxylic acid, PEG(COOH), was synthesized and employed as the polymeric additive. The setting behavior, anti-washout ability, mechanical property, degradation rate, and osteogenic capacity of brushite CPC were regulated by incorporating PEG(COOH). The incorporation of PEG(COOH) with carboxylic acid groups demonstrated a positive effect on both mechanical properties and osteogenic activity in bone repair. This study offers valuable insights and suggests a promising strategy for the development of materials in bone tissue engineering.
- 11 March 2024
- Published by American Chemical Society (ACS) in ACS Biomaterials Science & Engineering
- Vol. 10 (4) , 2062-2067
Simultaneous Regulation of the Mechanical/Osteogenic Capacity of Brushite Calcium Phosphate Cement by Incorporating with Poly(ethylene glycol) Dicarboxylic Acid
Brushite calcium phosphate cement (brushite CPC) is a prospective bone repair material due to its ideal resorption rates in vivo. However, the undesirable mechanical property and bioactivity limited its availability in clinic application. To address this issue, incorporating polymeric additives has emerged as a viable solution. In this study, poly(ethylene glycol) dicarboxylic acid, PEG(COOH), was synthesized and employed as the polymeric additive. The setting behavior, anti-washout ability, mechanical property, degradation rate, and osteogenic capacity of brushite CPC were regulated by incorporating PEG(COOH). The incorporation of PEG(COOH) with carboxylic acid groups demonstrated a positive effect on both mechanical properties and osteogenic activity in bone repair. This study offers valuable insights and suggests a promising strategy for the development of materials in bone tissue engineering.
- 28 October 2023
- Published by American Chemical Society (ACS) in The Journal of Organic Chemistry
- Vol. 88 (22) , 15964-15968
Synthesis of Fused-Ring Derivatives Containing Bifluorenylidene Units via Pd-Catalyzed Tandem Multistep Suzuki Coupling/Heck Cyclization Reaction
A series of bifluorenylidene derivatives has been facilely synthesized via a palladium-catalyzed tandem multistep Suzuki cross-coupling and Heck cyclization in one pot. The tandem reaction involves two sequential Suzuki couplings and a subsequent Heck cyclization. The target products are obtained in good yields up to 94%. Even in an extended conjugated substrate, the anticipated products can be prepared.
- 28 October 2023
- Published by American Chemical Society (ACS) in The Journal of Organic Chemistry
- Vol. 88 (22) , 15964-15968
Synthesis of Fused-Ring Derivatives Containing Bifluorenylidene Units via Pd-Catalyzed Tandem Multistep Suzuki Coupling/Heck Cyclization Reaction
A series of bifluorenylidene derivatives has been facilely synthesized via a palladium-catalyzed tandem multistep Suzuki cross-coupling and Heck cyclization in one pot. The tandem reaction involves two sequential Suzuki couplings and a subsequent Heck cyclization. The target products are obtained in good yields up to 94%. Even in an extended conjugated substrate, the anticipated products can be prepared.